Capital Markets Day 2023
Ipsen plans to host a capital-markets day, starting at 12.30 pm GMT on 7 December 2023, at The Brewery, London. In-person attendance is by invitation only.
The event will be webcast live.
WEBCAST REGISTRATION
The event will be broadcast live via a webcast, with the opportunity for online participants to ask questions in real-time. Register for access to join the event. Additionally, a replay of the event will be made available for later viewing on ipsen.com.
Register NowSpeakers
As well as an opportunity to meet management, the event will focus on R&D strategy, pipeline opportunities, the drivers of key on-market medicines, as well as a mid-term outlook.
IPSEN IN BRIEF
Our vision is to be a leading global mid-sized biopharmaceutical company with a focus on transformative medicines in Oncology, Rare Disease and Neuroscience.
Discover Ipsen in two pages; our medicines and key figures, our objectives and our strategy.
Your dedicated contacts
-
Craig Marks
Vice President, Investor Relations
-
-
Nicolas Bogler
Senior Manager, Investor Relations
-
Financial results for the first half of 2024
Test Story
FY 2023 results announcement (post announcement page update)
Ipsen’s partnership with Marengo
Ipsen’s 2022 Integrated Annual Report now available
Applications now open for the 2023 Golden Ticket Competition
Ipsen anti-corruption system certification renewed in 2022
A message from CEO David Loew
How to transform the medical organization in specialty care to drive best-in-class patient value
